Announced Tue, 21 Jul · 16:39 IST
Nureca Q1 FY27 results: revenue up about 18%, PAT jumps over 4x YoY
NURECA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.8%1-day move
₹293.00
prior close
₹324.99
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.8-1.2-1.2-3.0+0.8+3.9+7.8———————
Up moveDown movePending
AI summary
Nureca reported strong Q1 FY27 results. Standalone revenue rose 17.7% YoY to Rs 403.96M from Rs 343.24M. Standalone PAT jumped to Rs 24.32M from Rs 5.52M, a roughly 4x rise. Consolidated revenue grew 18% to Rs 403.43M with PAT at Rs 30.67M versus Rs 8.13M. Margins expanded sharply versus a year ago and versus the loss-making Q4 FY26. Statutory auditor Singhi and Co gave an unmodified limited review opinion.
Likely market impact
Sharp recovery from Q4 FY26 losses with strong YoY PAT growth and margin expansion, positive signal for the stock.